Efficacy and Safety Study of GerEPO

PHASE3CompletedINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

November 30, 2005

Conditions
Chronic Renal Failure Related Anemia
Interventions
DRUG

GerEPO

Trial Locations (32)

10990

Penang General Hospital, Pulau Pinang

14000

Asia Renal Care,Bukit Mertajam, Bukit Mertajam

15590

Hospital Kota Bharu, Kota Bharu

20400

Hospital Kuala Terengganu, Kuala Terengganu

30990

Hospital Ipoh, Ipoh

34000

Hospital Taiping, Taiping

41200

Hospital Tengku Ampuan Rahimah, Klang

46150

Haemodialysis Unit , Sunway Medical Centre, Petaling Jaya

50400

SP Menon Dialysis Centre, Kuala Lumpur

54000

Pusat Hemodialisis, Yayasan Felda, Kuala Lumpur

58100

The Kidney Dialysis Centre, Kuala Lumpur

59100

Pantai Medical Centre, Kuala Lumpur, Kuala Lumpur

70300

Pusat Hemodialisis Mawar (Seremban), Seremban

Seremban General Hospital, Seremban

75400

Hospital Melaka, Malacca

80100

Hospital Sultanah Aminah, Johor Bharu

82000

Pontian Rotary Haemodialysis Centre, Pontian Besar

88100

Persatuan Buah Pinggang Sabah, Kota Kinabalu

88586

Hospital Queen Elizabeth, Kota Kinabalu

93250

Timberland Medical Centre, Kuching

93540

MAA Medicare Kidney Charity Dialysis Centre, Kuching

93586

Hospital Umum Sarawak, Kuching

05100

Hospital Alor Setar, Alor Star

Unknown

Hospital Kuala Lumpur, Kuala Lumpur

Tung Shin Hospital, Kuala Lumpur

Hospital Tengku Ampuan Afzan, Kuantan

Pahang Buddhist Association, Kuantan

Ampang Putri Specialist Hospital, Ampang

Hospital Selayang, Batu Caves

SP Menon Dialysis Centre, Klang

SP Menon Dialysis Centre, Megah Medical Specialist Centre, Petaling Jaya

01000

Hospital Kangar, Kangar

All Listed Sponsors
lead

Ministry of Health, Malaysia

OTHER_GOV

NCT00229099 - Efficacy and Safety Study of GerEPO | Biotech Hunter | Biotech Hunter